EFPIA welcomes new agreement on General Data Protection Regulation

19 December 2015
efpia-big

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed an agreement reached this week by the European Institutions on the General Data Protection Regulation.

The agreement, which has been four years in the making, aims to create strong data protection law for Europe’s 500 million citizens and will replace an outdated patchwork of national rules across the 28 member states.

The EFPIA said it plans to work with national authorities, the European Commission, academia, patients’ associations and other stakeholders during the implementation period to put in place a system that will boost research in Europe while protecting the privacy of empowered patients.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical